Alpha 2.0
Login Register
» Articles » PMID: 32028515

Reduction of Blood Pressure Variability: an Additional Protective Cardiovascular Effect of Vasodilating Beta-blockers?

Overview
Journal J Hypertens
Specialty Cardiology & Vascular Diseases
Date 2020 Feb 7
PMID 32028515
Citations 6
Authors
Rita Del Pinto
Claudio Ferri
Gianfranco Parati
Affiliations
Soon will be listed here.
Citing Articles

Physicians' attitudes toward beta-blockers for the treatment of hypertension in Italy, Poland, and Turkey.

Prejbisz A, Donnaloja F, Dobrowolski P, Tettamanti A, Januszewicz A, Zoghi M J Clin Hypertens (Greenwich). 2024; 26(6):624-634.

PMID: 38750668 PMC: 11180681. DOI: 10.1111/jch.14819.

Drug repurposing for cancer therapy.

Xia Y, Sun M, Huang H, Jin W Signal Transduct Target Ther. 2024; 9(1):92.

PMID: 38637540 PMC: 11026526. DOI: 10.1038/s41392-024-01808-1.

Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.

Del Mauro J, Prince P, Plantamura Y, Allo M, Parola L, Fernandez Machulsky N Hypertens Res. 2021; 44(7):791-802.

PMID: 33612826 DOI: 10.1038/s41440-021-00630-4.

Long-term BP variability: open questions in clinical practice.

Del Pinto R, Ferri C Int J Cardiol Hypertens. 2021; 7:100064.

PMID: 33447785 PMC: 7803056. DOI: 10.1016/j.ijchy.2020.100064.

Prognostic importance of long-term SBP variability in high-risk hypertension.

Del Pinto R, Pietropaoli D, Dobre M, Ferri C J Hypertens. 2020; 38(11):2237-2244.

PMID: 32649637 PMC: 9125745. DOI: 10.1097/HJH.0000000000002552.